PEPTIDE COMPARISON

Tirzepatide vs Semaglutide

Two approved metabolic medicines compared without flattening product labels or trial populations.

QUICK ANSWER

Tirzepatide vs Semaglutide: the main difference.

Both ingredients have mature clinical programs, but head-to-head interpretation must use the specific products, doses, populations, and outcomes studied. Approval of either ingredient does not make compounded versions equivalent to FDA-approved products.

Decision field	Tirzepatide	Semaglutide
Human research	Large randomized and post-approval programs	Large randomized and outcomes programs
Receptors	GIP + GLP-1	GLP-1
FDA status	Approved branded products for defined indications	Approved branded products for defined indications
Evidence boundary	Results depend on product, dose, population, and endpoint	Results depend on product, dose, population, and endpoint
Compounded products	Not FDA approved	Not FDA approved

SOURCES

Tirzepatide vs Semaglutide sources.

FDA / 2026Zepbound prescribing informationU.S. FDA FDA / 2024FDA approves first medication for obstructive sleep apneaU.S. FDA FDA / 2026Wegovy application and labeling recordU.S. FDA FDA / 2026FDA concerns with unapproved GLP-1 drugsU.S. FDA

Tirzepatide vs Semaglutide: the main difference.

Tirzepatide vs Semaglutide sources.

Questions related to Tirzepatide vs Semaglutide.

Compare the next decision.